Chiara Romagnani

Title: Chiara Romagnani: Innovator in Immunotherapy

Introduction

Chiara Romagnani is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunotherapy, particularly in the activation and expansion of natural killer (NK) cells. Her innovative work has the potential to impact the treatment of various medical conditions associated with pathogenic cells.

Latest Patents

Chiara Romagnani holds a patent for her invention titled "Activation and expansion of NKG2C+ NK cells." This invention relates to an isolated peptide that consists of 9 to 30 amino acids, specifically an amino acid sequence according to SEQ ID NO 1 (VMAPRTLXL). The peptide is designed for use as a medicament to expand and activate NKG2C+ NK cells. Furthermore, it is intended for the treatment and prevention of medical conditions associated with pathogenic cells expressing HLA-E. The invention also includes a genetically modified virus encoding the peptide for therapeutic use.

Career Highlights

Chiara Romagnani is affiliated with the Deutsches Rheuma-Forschungszentrum Berlin, where she conducts her research and development activities. Her work has garnered attention for its innovative approach to enhancing immune responses through NK cell activation.

Collaborations

Chiara collaborates with notable colleagues, including Timo Rückert and Quirin Hammer, who contribute to her research endeavors and the advancement of her inventions.

Conclusion

Chiara Romagnani's contributions to immunotherapy through her innovative patent highlight her role as a leading inventor in the field. Her work promises to pave the way for new therapeutic strategies in combating diseases associated with pathogenic cells.